Sulforaphane exhibits antiviral activity against pandemic SARS-CoV-2 and seasonal HCoV-OC43 coronaviruses in vitro and in mice

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), the cause of coronavirus disease 2019 (COVID-19), has incited a global health crisis. Currently, there are limited therapeutic options for the prevention and treatment of SARS-CoV-2 infections. We evaluated the antiviral activity of sulfo...

Descripción completa

Detalles Bibliográficos
Autores principales: Ordonez, Alvaro A., Bullen, C. Korin, Villabona-Rueda, Andres F., Thompson, Elizabeth A., Turner, Mitchell L., Merino, Vanessa F., Yan, Yu, Kim, John, Davis, Stephanie L., Komm, Oliver, Powell, Jonathan D., D’Alessio, Franco R., Yolken, Robert H., Jain, Sanjay K., Jones-Brando, Lorraine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8933402/
https://www.ncbi.nlm.nih.gov/pubmed/35304580
http://dx.doi.org/10.1038/s42003-022-03189-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8933402/
https://www.ncbi.nlm.nih.gov/pubmed/35304580
http://dx.doi.org/10.1038/s42003-022-03189-z

Ejemplares similares